drugset / Trial / NCT02004132

A Study of Axiron® in Healthy Participants

NCT02004132

Phase 1 Completed 12 enrolled Eli Lilly and Company
NaSingle-groupOpen-labelBasic science

Summary

The study involves application of Axiron to each underarm. The study will evaluate the transfer of testosterone from underarms to the clothing items that the participant is wearing and other fabric items washed with participant's' clothes. The study is approximately 6 days, not including screening. Screening is required within 28 days prior to the start of the study.

Timeline

Start
2013-12
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule Topical

Indications

No indication recorded.